By: Jennifer Galvet, PharmD Candidate c/o 2024 Farxiga (dapagliflozin) is a first-in-class, oral, once daily sodium-glucose cotransporter 2 (SGLT2)…
By: Sairah Sheikh, PharmD Candidate c/o 2024 Promising new research conducted by doctors at Memorial Sloan Kettering Cancer Center…
Featuring: Ali Baig, PharmD Candidate c/o 2023By: Helen Li, PharmD Candidate c/o 2023 Ali Baig is a sixth-year pharmacy student…
By: Imaan Sekhery, PharmD Candidate c/o 2025 On July 6, 2022, the Food and Drug Administration (FDA) revised the…
By: Geraldine Ciaccio, PharmD Candidate c/o 2025 Young children with type 1 diabetes (T1D) are completely dependent on others…
By: Kelly Lavery, PharmD Candidate c/o 2024 Increasing rates of childhood obesity remain a major risk factor behind a…
Featuring: Colleen Bond, PharmD, BCPSBy: Justin Budz, PharmD Candidate c/o 2023 At a young age, Dr. Colleen Bond was involved…
By: Zarin Chowdhury, PharmD Candidate c/o 2023 and Lauren Merkovich, PharmD Candidate c/o 2023 Type 2 diabetes (T2D) is…
By: Pauline Choi, PharmD There has been an increase in the prevalence of obesity, and it has become an…
Featuring: Khushbu Doshi, PharmD Candidate c/o 2023By: Justin Budz, PharmD Candidate c/o 2023 Khushbu Doshi is a sixth-year pharmacy student…